TY - JOUR T1 - Longitudinal SARS-CoV-2 serosurveillance of over ten thousand health care workers in the Providence Oregon cohort JF - medRxiv DO - 10.1101/2020.08.16.20176107 SP - 2020.08.16.20176107 AU - Rom Leidner AU - Angi Frary AU - Julie Cramer AU - David Ball AU - Roshanthi Weerasinghe AU - Mark Schmidt AU - Justin Jin AU - Veronica Luzzi AU - Alec Saitman AU - Jeffrey A. Young AU - David Leidner AU - Kendall Sawa AU - Scott Marsal AU - Kevin Olson AU - Nancy Frisco AU - Amy Compton-Phillips AU - Walter Urba AU - Brian Piening AU - Carlo Bifulco Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/18/2020.08.16.20176107.abstract N2 - Frontline healthcare workers (HCW) are a high-risk population for SARS-CoV-2 infection. Here we present results from a large serosurveillance study of 10,019 asymptomatic HCW conducted during April-May 2020, in eight hospital medical centers across the state of Oregon, USA during the initial peak of the pandemic. Free and voluntary testing was performed at 14 +/− 3 day intervals, over a 4-week window at each site, utilizing a lab-developed ELISA based on the Epitope Diagnostics COVID-19 nucleocapsid IgG detection Kit. We identified 253 SARS-CoV-2 IgG seropositive individuals among 10,019 total participants, representing a cross-sectional seroprevalence of 2.53%. Subgroup analysis identified differential seropositivity by job role, ranging from 8.03% among housekeepers, odds ratio 3.17 (95% CI 1.59–5.71), to 0.00% among anesthesiologists, odds ratio 0.00 (95% CI 0–0.26), both of which were significant. Over the course of the study, 17 seroconversions (0.25%) and 101 seroreversions (1.50%) were identified. Self-reported SARS-CoV-2 swab qPCR testing, when compared with subsequent serology on study, showed only modest agreement, κ = 0.47 (95% CI 0.32–0.62). Overall, these findings demonstrate relatively low seroprevalence and very low seroconversion rates among HCW in Oregon, USA, over a period in which aggressive social distancing measures were in place. The high rate of seroreversion observed in this cohort, and the relatively high discordance between SARS-CoV-2 serology and swab qPCR, highlight limitations of current detection methods, and stress the need for development of novel assessment methodologies to more accurately identify exposure (and/or immunity) to SARS-CoV-2 in this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded by Providence St. Joseph Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Providence St. Joseph Health IRB approved protocol (PSJH IRB2020000221, entitled: SARS-CoV-2 Serosurveillance Protocol for PSJH Health Care Workers).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available in supplemental section. ER -